Abstract
BackgroundAlcohol-related liver disease (ARLD) is the leading cause of cirrhosis and liver-related mortality in the UK but few interventional clinical trials have been completed in this patient group. Such patients...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
